Why Gleevec-type Drugs Control, But Do Not Eradicate, Leukemia

Researchers are closer to understanding why certain chronic myeloid leukemia mutations are not stopped by the revolutionary targeted cancer pill, Gleevec, or similar therapies in that drug family.